Ep. 173 - EU VC Funds, Abortion Drug Ruling, IRA Insights

from BioCentury This Week · host BioCentury

Top-tier European VCs are still attracting capital to deploy, Director of Biopharma Intelligence Stephen Hansen said on the latest BioCentury This Week podcast, with LPs looking at funds’ track record and the track record for biotech. Hansen discusses how Forbion and Gilde will deploy their newly announced funds as well as what’s new in their strategies as they raise some of the biggest VC vehicles ever in Europe. BioCentury’s editors also discuss the U.S. Supreme Court’s mifepristone ruling and comments filed by the biopharma industry about CMS’s draft guidance on implementing the Inflation Reduction Act.Reach us by sending a text

Episode metadata supplied by the publisher feed · Published Apr 25, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 173 - EU VC Funds, Abortion Drug Ruling, IRA Insights

0:00 23:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioCentury This Week?

This episode is 23 minutes long.

When was this BioCentury This Week episode published?

This episode was published on April 25, 2023.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!